Get my own profile
Public access
View all9 articles
1 article
available
not available
Based on funding mandates
Co-authors
Robert A. HoltHead of Sequencing, Michael Smith Genome Sciences Centre, BC Cancer Agency Distinguished ScientistVerified email at bcgsc.ca
RL WarrenGenome Sciences Centre, BC CancerVerified email at bcgsc.ca
Richard A MooreMichael Smith Genome Sciences Centre, BC CancerVerified email at bcgsc.ca
Martin KrzywinskiGenome Sciences Center, BC Cancer Research CenterVerified email at bcgsc.ca
Carl JuneUniversity of PennsylvaniaVerified email at upenn.edu
Brad H NelsonDirector, Deeley Research Centre, BC Cancer AgencyVerified email at bccancer.bc.ca
john webbBritish Columbia Cancer Agency / Deeley Research CentreVerified email at bccrc.ca
Joseph A. FraiettaUniversity of PennsylvaniaVerified email at upenn.edu
Yangbing ZhaoUTC Therapeutics.IncVerified email at utctherapeutics.com
Julie S. NielsenLeader, Cell Manufacturing, BC Cancer's Immunotherapy ProgramVerified email at bccancer.bc.ca
Spencer D. Martin, MD PhDDepartment of Pathology and Laboratory Medicine, Faculty of Medicine, University of British columbiaVerified email at vch.ca
Kwame Twumasi-BoatengTelix PharmaceuticalsVerified email at telixpharma.com
Avery D. Posey, Jr.University of PennsylvaniaVerified email at pennmedicine.upenn.edu
Wyeth WassermanProfessor of Medical Genetics, University of British ColumbiaVerified email at cmmt.ubc.ca
Kathleen G BanksUniversity of British ColumbiaVerified email at ubc.ca
Elizabeth M. SimpsonProfessor of Medical Genetics, Univeristy of British ColumbiaVerified email at cmmt.ubc.ca
Anthony MathelierAssociate Director and Group Leader, Centre for Molecular Medicine Norway (NCMM)Verified email at ncmm.uio.no
Steven JonesBC Cancer, Simon Fraser University, University of British ColumbiaVerified email at bcgsc.ca
Christopher C KlossJohnson and Johnson
Follow
Mauro Castellarin
Research Associate, University of Pennsylvania, Center for Cellular Immunotherapies
Verified email at pennmedicine.upenn.edu